Objectives: To evaluate morbidity and mortality among critically injured children with acute respiratory distress syndrome. Design: Retrospective cohort study. Setting: Four-hundred sixty Level I/II adult or pediatric trauma centers contributing to the National Trauma Data Bank. Patients: One hundred forty-six thousand fifty-eight patients less than 18 years old admitted to an ICU with traumatic injury from 2007 to 2016. Interventions: None.
Measurements and Main Results:
We assessed in-hospital mortality and need for postdischarge care among patients with and without acute respiratory distress syndrome and hospital resource utilization and discharge disposition among survivors. Analyses were adjusted for underlying mortality risk (age, Injury Severity Score, serious brain or chest injury, and admission heart rate and hypotension) and year, transfer status, and facility trauma level designation. Acute respiratory distress syndrome occurred in 2,590 patients (1.8%). Mortality was 20.0% among acute respiratory distress syndrome patients versus 4.3% among nonacute respiratory distress syndrome patients, with an adjusted relative risk of 1.76 (95% CI, 1.52-2.04). Postdischarge care was required in an additional 44.8% of acute respiratory distress syndrome patients versus 16 .0% of patients without acute respiratory distress syndrome (adjusted relative risk, 3.59; 2.87-4.49), with only 35.1% of acute respiratory distress syndrome patients discharging to home versus 79.8% of patients without acute respiratory distress syndrome. Acute respiratory distress syndrome mortality did not change over the 10-year study period (adjusted relative risk, 1.01/ yr; 0.96-1.06) nor did the proportion of acute respiratory distress syndrome patients requiring postdischarge care (adjusted relative risk, 1.04/yr; 0.97-1.11). Duration of ventilation, ICU stay, and hospital stay were all significantly longer among acute respiratory distress syndrome survivors. Tracheostomy placement occurred in 18.4% of acute respiratory distress syndrome survivors versus 2.1% of patients without acute respiratory distress syndrome (adjusted relative risk, 3.10; 2.59-3.70). Conclusions: Acute respiratory distress syndrome development following traumatic injury in children is associated with significantly increased risk of morbidity and mortality, even after adjustment for injury severity and hemodynamic abnormalities. Outcomes have not improved over the past decade, emphasizing the need for new therapeutic interventions, and prevention strategies for acute respiratory distress syndrome among severely injured children. (Crit Care Med 2019; 47:e112-e119) Key Words: acute respiratory distress syndrome; child; intensive care units; hospital mortality; outcome assessment; trauma centers T raumatic injury is the leading cause of death and new disability in children and adolescents in the United States (1) . Although most deaths occur immediately or within hours of the injury, over one quarter of pediatric trauma deaths are characterized as "late mortality", occurring after at least 24 hours of hospitalization (2) . Children who survive to hospital admission remain at risk for life-threatening complications of their initial injury, the most common being acute respiratory distress syndrome (ARDS) (2) . ARDS can be triggered by direct pulmonary insults such as pneumonia and aspiration, or by systemic inflammation, as with sepsis and trauma (3) . Mortality among children with ARDS of all etiologies ranges from 13% to 44% depending on the patient population (4) (5) (6) (7) (8) (9) (10) (11) (12) , highlighting the heterogeneity of the syndrome. A recent meta-analysis found a combined mortality rate of 27.3% for pediatric ARDS in Western countries (13) . Most pediatric ARDS studies have included very few trauma patients, however; while one recent study assessed inhospital mortality among a mixed population of trauma, burn, and drowning patients (14) , none have evaluated outcomes among trauma patients specifically or assessed postdischarge morbidity. It therefore remains unclear whether mortality among children with posttraumatic ARDS is similar to that of ARDS due to other etiologies or what the impact of ARDS is on survivors of pediatric trauma.
A challenge in studying posttraumatic ARDS is to distinguish the effect of ARDS on outcomes from the impact of the severity of the injury itself. Although most adult studies have found that unadjusted mortality is higher among patients with ARDS than those without (15) (16) (17) (18) (19) (20) (21) , several have found no additional impact of ARDS on mortality after adjusting for confounding factors such as age, injury severity, and physiologic variables at admission (15, 16) . We therefore aimed to evaluate outcomes among pediatric patients with posttraumatic ARDS by estimating risk for all-cause hospital mortality after adjusting for underlying mortality risk, and assessing markers of morbidity among survivors including hospital resource utilization and need for ongoing postdischarge care. Improved understanding of how ARDS impacts outcomes in critically injured children will enable better assessment of the efficacy of interventions and allow identification of areas for targeted support for survivors.
MATERIALS AND METHODS
We conducted a retrospective cohort study of children admitted to ICUs at trauma centers included in the National Trauma Data Bank (NTDB) (21) from 2007 to 2016. This study was exempt from review by the University of Washington Institutional Review Board as data were deidentified and not considered to be human subjects research.
Participants
We used the NTDB research datasets from 2007 to 2016 to identify pediatric trauma patients. The NTDB contains more than 7 million records from more than 1,000 U.S. and Canadian facilities and is the largest trauma registry worldwide, representing nearly all Level I or II adult or pediatric trauma centers in the United States (22) . Patients with traumatic injury who are transferred via Emergency Medical Services or sustain injuries resulting in hospital admission or death are eligible for inclusion. We included patients less than 18 years old with greater than or equal to 1 ICU day at a Level I or II adult or pediatric trauma center. We excluded patients admitted with burns/inhalation (n = 6,302) or drowning (n = 429), as the physiologic mechanism for ARDS development is likely different in these patients than other trauma patients, and the NTDB is not a representative database for these patients. Patients from nine facilities that do not routinely report hospital complications were excluded (n = 1,805).
Identification of ARDS
ARDS is recorded in the NTDB as a hospital complication for patients who met American-European Consensus Conference criteria (23) through 2011, modified Berlin criteria (24) from 2012 to 2014, and full Berlin criteria from 2015 to 2016 (Supplemental Digital Content 1, http://links.lww.com/ CCM/E161). The NTDB does not record whether an intervening event occurred between the injury and ARDS onset, and our findings are thus inclusive of the full scope of ARDS triggers that patients are susceptible to following traumatic injury, including direct chest trauma, severe systemic inflammation, transfusion-associated lung injury, aspiration, and pneumonia.
Covariates
We used a modification of the risk adjustment model by Haider et al (25) for underlying risk of mortality among patients of all ages in the NTDB, which included six covariates (age, Injury Severity Score [ISS], admission heart rate, admission hypotension, total admission Glasgow Coma Scale [GCS] score, and ventilator use) with an area under the receiver operating characteristics curve of 0.9578 for mortality prediction. In our cohort, however, 54% of ARDS patients were intubated, chemically paralyzed, or had an eye injury at admission, rendering total GCS unreliable. Additionally, 88% of patients with ARDS were mechanically ventilated, leading to collinearity between ventilator use and ARDS. We thus substituted total GCS and ventilator use with the presence of a serious brain or chest injury (defined by a region-specific Abbreviated Injury Scale [AIS] severity score ≥ 3), two factors that contribute substantially to GCS and need for mechanical ventilation but with more discriminative ability in this cohort. Our final set of covariates for risk adjustment thus included age, ISS, brain injury with AIS greater than or equal to 3, chest injury with AIS greater than or equal to 3, admission heart rate, and admission hypotension. Heart rate and hypotension were categorized using age-adjusted normative values (26, 27) .
Outcomes
We assessed in-hospital mortality and postdischarge care needs among survivors by categorizing patients by discharge disposition: 1) discharge to home with no homecare services; 2) ongoing care needs including transfer to a second acute care facility, inpatient rehabilitation, skilled nursing facility, long-term care facility, home care, or other (hospice, psychiatric care, left against medical advice, or unspecified facility); and 3) expired. We also assessed whether the frequency of mortality and need for postdischarge care changed from 2007 to 2016. Outcomes assessed among survivors were duration of mechanical ventilation, frequency of tracheostomy placement, ICU and hospital length of stay (LOS), and type of postdischarge care required.
Statistical Analysis
We calculated rates of each outcome for patients with and without ARDS. We estimated associations between ARDS and each outcome in bivariate analyses clustered by facility using generalized linear Poisson regression for death and tracheostomy, multinomial logistic regression for discharge disposition, and linear regression for duration of ventilation and LOS. We repeated each analysis as a multivariable model with the six predetermined covariates, as well as admission year, transfer status, and facility trauma level designation, to estimate adjusted associations between ARDS and each outcome. We determined annual rates of mortality and postdischarge care among patients with and without ARDS and estimated associations between year and discharge disposition in bivariate analyses and as multivariable models with the predetermined covariates. All models were complete case analyses; no covariates had greater than 5% missing data. We conducted all analyses using Stata/SE 14.2 statistical software (StataCorp LP, College Station, TX).
RESULTS
A total of 146,058 patients from 460 facilities met inclusion criteria, with an ARDS incidence of 1.8% (n = 2,590). Two thirds of patients were male, and just over half were nonHispanic white. Patients with ARDS were slightly older than those without ARDS (mean 10.4 vs 9.5 yr), and a higher proportion were African American (20.8% vs 14.5%). Motor vehicle crashes were the most common mechanism of injury among ARDS patients, whereas falls were most common among non-ARDS patients. ARDS patients had a higher median ISS (26 vs 13) and higher frequency of brain injury, chest injury, abnormal admission heart rate, and admission hypotension ( Table 1) .
The mortality rate among ARDS patients was 20.0% versus 4.3% among patients without ARDS. Among patients without a serious brain injury, 9.2% of ARDS patients and 0.9% of non-ARDS patients died. Median time to death was 3 days (interquartile range [IQR], 1-6 d) among ARDS patients and 2 days (IQR, 1-4 d) among non-ARDS patients. Ongoing postdischarge care was required in an additional 44.8% of ARDS patients, compared with 16.0% of non-ARDS patients. Only 35.1% of patients with ARDS discharged to home without need for further care, whereas 79.8% of patients without ARDS discharged to home without services (Fig. 1) .
The relative risk (RR) of mortality among ARDS patients compared to those without ARDS was 4.70 (95% CI, 4.14-5.34). The RR of requiring postdischarge care (vs discharge home without homecare services) was 6.37 (95% CI, 5.26-7.72). After adjusting for the selected covariates, the adjusted RR (aRR) for mortality was 1.76 (95% CI, 1.52-2.04), and the aRR for postdischarge care was 3.59 (95% CI, 2.87-4.49) ( Table 2) .
Hospital Complications and Procedures
Patients with ARDS experienced higher rates of other hospital complications than non-ARDS patients, including pneumonia (20.6% vs 2.3%), sepsis or bacteremia (4.5% vs 0.4%), other infections (4.5% vs 1.1%), and cardiac arrest (8.2% vs 0.8%), although it is unknown whether these complications preceded ARDS onset (Supplemental Digital Content 2, http://links. lww.com/CCM/E162). Among patients with ARDS, development of pneumonia was associated with a lower risk of death relative to patients without pneumonia (aRR, 0.45; 95% CI, 0.36-0.58), whereas cardiac arrest was associated with a higher risk of death (aRR, 3.03; 95% CI, 2.46-3.72). Neither sepsis/ bacteremia nor other infections were associated with risk of death. All hospital complications evaluated were associated with higher risk for postdischarge care.
Patients with ARDS more frequently underwent surgical procedures within 24 hours of hospital arrival, but none of the procedures assessed were associated with higher mortality risk among ARDS patients (Supplemental Digital Content 2, http://links.lww.com/CCM/E162). Spinal fusion was associated with higher risk of postdischarge care.
Trends Over Time
Annual ARDS mortality ranged from 16.2-24.9% over the 10-year study period but had no significant linear trend over time before risk adjustment (RR 1.01/yr, 95% CI 0.96-1.05) and after adjustment (aRR, 1.01/yr; 95% CI, 0.96-1.06). The proportion of ARDS patients who required postdischarge care also did not significantly change over time, ranging from 40.5% to 55.1% annually with no linear trend before or after risk adjustment (RR, 1.01/yr; 95% CI, 0.95-1.07 and aRR, 1.04/yr; 95% CI, 0.97-1.11) (Fig. 2) .
Treatment and Outcomes Among ICU Survivors
Among patients who survived to hospital discharge, the duration of mechanical ventilation, ICU LOS, and hospital LOS were all significantly longer among patients with ARDS in both unadjusted and risk-adjusted analyses (Fig. 3) . Median ventilator duration was 6 days (IQR, 3-12 d) for ARDS patients compared with 2 days (IQR, 1-6 d) for non-ARDS patients. After risk adjustment, the average duration of mechanical ventilation was 3.10 days (95% CI, 2.74-3.47) longer among ARDS patients than non-ARDS patients. Median ICU LOS among ARDS patients was 10 days (IQR, 4-18 d) versus 2 days (IQR, 1-3 d) in non-ARDS patients, with an average adjusted ICU LOS that was 6.53 days (95% CI, 6.29-6.78) longer among ARDS patients. ARDS patients had a median 16-day hospital stay (IQR, 9-26 d) compared with 4 days (IQR, 2-7 d) among non-ARDS patients. The average adjusted hospital LOS was 9.08 days (95% CI, 8.67-9.49) longer among ARDS patients than non-ARDS patients.
Tracheostomy placement occurred in 18.4% of ARDS patients who survived to hospital discharge compared with 2.1% of survivors without ARDS. Among survivors without a serious brain injury, 13.7% of ARDS patients and 1.1% of non-ARDS patients received a tracheostomy. Adjusted RRs are adjusted for age, Injury Severity Score, presence of a traumatic brain injury with an Abbreviated Injury Scale severity score ≥ 3, presence of a chest injury with an Abbreviated Injury Scale severity score ≥ 3, admission heart rate, admission hypotension, year, transfer status, and facility trauma level designation.
Of patients who survived ARDS, 56.0% required ongoing postdischarge care. Inpatient rehabilitation was the most common type (29.7% of survivors), followed by care in long-term care facilities (10.6%). In contrast, only 16.7% of survivors without ARDS required postdischarge care. Half (8.6% of survivors) received inpatient rehabilitation, with home healthcare the second most common (2.9%) type of postdischarge care (Supplemental Digital Content 3, http://links.lww.com/CCM/E163).
Among survivors without a serious brain injury, 44.1% of ARDS patients and 13.0% of non-ARDS patients required postdischarge care. Patients with ARDS remained significantly more likely than patients without ARDS to experience all types of postdischarge care after risk adjustment, especially for care in long-term care facilities (aRR, 5.10; 95% CI, 3.21-8.11) and skilled nursing facilities (aRR, 4.91; 95% CI, 3.48-6.94) ( Table 2) .
DISCUSSION
Although ARDS is a known complication of severe traumatic injury, its impact on outcomes in the pediatric trauma population has not previously been described. The findings of this 10-year cohort of nearly 150,000 critically injured children suggest that the development of ARDS is significantly associated with all-cause morbidity and mortality even after adjusting for important confounding factors. This study also demonstrates that little progress has been made over the past decade in improving outcomes for pediatric trauma patients with ARDS.
Several studies of adult ARDS have found lower inhospital mortality among patients with posttraumatic ARDS compared with other etiologies (28, 29) , but this has not been evaluated in children. The all-cause mortality rate of 20.0% among patients with posttraumatic ARDS in our cohort is similar to the overall pediatric ARDS mortality rate found in many recent studies (5, 7, 8, (10) (11) (12) , and the 9.2% mortality among ARDS patients without serious brain injury is consistent with the mortality rate among general pediatric ARDS patients who did not die of neurologic causes (12) . There was a nearly five-fold higher risk of death among ARDS patients compared with those without ARDS, and a 76% higher risk for mortality after adjusting for confounding factors.
Furthermore, the impact of ARDS on survivors of pediatric trauma is substantial, with less than half of ARDS survivors discharging to home. Although injury severity and serious neurologic injury contribute greatly to postdischarge care needs after trauma, ARDS patients remained over three times more likely to require ongoing care after discharge than non-ARDS patients after adjusting for these factors. Prolonged duration of mechanical ventilation, high rates of tracheostomy placement, and markedly longer lengths of stay in ARDS patients likely contributed to deconditioning and ongoing respiratory care needs.
The finding that 18.4% of ARDS survivors underwent tracheostomy placement is striking, especially considering that the median time to tracheostomy was only 10 days. Tracheostomy placement is a relatively rare event in PICU patients in general; a recent study of over 13,000 children mechanically ventilated for at least 72 hours found that only 6.6% received a tracheostomy, at a median 14.4 days after admission (30) . Tracheostomy placement in children, including trauma patients, has been shown to decrease ventilator duration and LOS (31, 32) . Unsurprisingly however, over 90% of ARDS survivors in our cohort who had a tracheostomy placed required ongoing postdischarge care, highlighting the fact that despite potential in-hospital benefits of tracheostomy placement, it is accompanied by a high burden of postdischarge care. Among pediatric patients in general, fewer than 50% of those with a tracheostomy are ever decannulated, and the average time to decannulation is 2 years (33). This has not been evaluated in the trauma population specifically however, and further work is necessary to better understand the risks and benefits of tracheostomy placement among pediatric trauma patients both during and after hospitalization.
Neither mortality nor the need for ongoing postdischarge care in pediatric posttraumatic ARDS significantly changed over the 10-year study duration. This is consistent with findings demonstrating that although there has been a significant decrease in overall pediatric ARDS mortality in Western countries since the 1980s, the downward trend is no longer observed among cohorts after 1994 (13) . Although improvements in ventilator strategy, fluid management, and transfusion practices likely contributed to initial declines (34), a plateau seems to have been reached for both pediatric ARDS mortality overall and for the trauma subpopulation, emphasizing the need for new therapeutic interventions and prevention strategies.
There were several limitations to this study. All patients included in this cohort predate the pediatric ARDS consensus criteria published in 2015 (35) , which have not yet been adopted by the NTDB. Instead, ARDS is identified in the NTDB based on adult ARDS consensus definitions, which likely underestimate ARDS occurrence in children (36) and may represent a more severely ill subpopulation of the patients who would have been identified by pediatric criteria (37, 38) . Risk adjustment was based on previously published recommendations for mortality risk adjustment in the NTDB but was not specific to PICU patients. Additionally, we substituted ventilator use and total GCS with presence of serious chest and brain injuries given the high prevalence of mechanical ventilation and GCS modifiers in our cohort; this approach has not been validated. It is possible that there are additional confounders of the association between ARDS and mortality that were not included in our risk adjustment strategy. We also elected to use the same covariates developed for mortality risk adjustment to adjust for morbidities, which has not been validated. Finally, we assumed that discharge to home without homecare services was due to lack of need for services, but it is possible that patients could not obtain services due to insurance limitations or lack of availability and that hospital stay was lengthened due to inability to discharge to a postacute care facility.
CONCLUSIONS
Development of ARDS after trauma in pediatric patients is accompanied by high rates of morbidity and mortality that have not decreased over the past decade. ARDS is associated with increased risk of mortality in critically injured children even after adjustment for injury severity, brain and chest injuries, and hemodynamic abnormalities, in contrast to several recent adult studies that have not found an independent effect of ARDS after risk adjustment. The burden of ARDS on trauma survivors is also substantial, with high rates of inhospital morbidity and low frequency of discharge to home without postdischarge health services. Characterization of the types of long-term morbidities that survivors of pediatric trauma-related ARDS face and identification of the potentially modifiable factors associated with morbidity are essential to guide interventions to improve long-term outcomes among severely injured children.
